Katus Ha

438 total citations
25 papers, 295 citations indexed

About

Katus Ha is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katus Ha has authored 25 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katus Ha's work include Cardiac electrophysiology and arrhythmias (7 papers), Cardiomyopathy and Myosin Studies (5 papers) and Cardiovascular Effects of Exercise (3 papers). Katus Ha is often cited by papers focused on Cardiac electrophysiology and arrhythmias (7 papers), Cardiomyopathy and Myosin Studies (5 papers) and Cardiovascular Effects of Exercise (3 papers). Katus Ha collaborates with scholars based in Germany, United States and Netherlands. Katus Ha's co-authors include Oliver J. Müller, Wolfgang M. Franz, Norbert Frey, Thomas Rothmann, Cordula Bittner, R. Hartong, H. Lorenzen, Marie Lange, Warner S. Simonides and Mathias Müller and has published in prestigious journals such as British Journal of Pharmacology, Cardiovascular Research and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Katus Ha

25 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katus Ha Germany 10 201 148 59 26 26 25 295
Marieke De Bruyne Belgium 8 203 1.0× 117 0.8× 59 1.0× 20 0.8× 15 0.6× 19 385
Elise L. Kessler Netherlands 10 193 1.0× 106 0.7× 23 0.4× 24 0.9× 38 1.5× 19 325
Adam J. Guenzel United States 10 91 0.5× 240 1.6× 58 1.0× 23 0.9× 19 0.7× 15 347
Taylor I. Liu United States 6 321 1.6× 55 0.4× 33 0.6× 15 0.6× 24 0.9× 10 378
Suzan Abedat Israel 10 194 1.0× 80 0.5× 36 0.6× 24 0.9× 86 3.3× 16 337
Charles M. Pearman United Kingdom 10 316 1.6× 131 0.9× 17 0.3× 9 0.3× 40 1.5× 25 403
Vinicius Tragante Netherlands 10 65 0.3× 131 0.9× 77 1.3× 15 0.6× 57 2.2× 21 286
Alice Ghidoni Italy 8 249 1.2× 131 0.9× 16 0.3× 9 0.3× 19 0.7× 13 338
Chia-Tung Wu Taiwan 8 240 1.2× 141 1.0× 11 0.2× 32 1.2× 41 1.6× 26 369

Countries citing papers authored by Katus Ha

Since Specialization
Citations

This map shows the geographic impact of Katus Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katus Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katus Ha more than expected).

Fields of papers citing papers by Katus Ha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katus Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katus Ha. The network helps show where Katus Ha may publish in the future.

Co-authorship network of co-authors of Katus Ha

This figure shows the co-authorship network connecting the top 25 collaborators of Katus Ha. A scholar is included among the top collaborators of Katus Ha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katus Ha. Katus Ha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akhavanpoor, Mohammadreza, et al.. (2017). The Two Faces of Interleukin-17A in Atherosclerosis.. Current Drug Targets. 18(7). 863–873. 9 indexed citations
2.
Neacșu, Ionela Andreea, Sven W. Sauer, Philip Raake, et al.. (2013). Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model. Gene Therapy. 21(2). 131–138. 31 indexed citations
3.
Pleger, Sven T., Katus Ha, & Raffi Bekeredjian. (2013). Hochgradige Mitralklappeninsuffizienz bei fortgeschrittener Herzinsuffizienz: Neues jenseits der Leitlinien. DMW - Deutsche Medizinische Wochenschrift. 138(12). 600–602. 1 indexed citations
4.
Schmidt, Constanze, Felix Wiedmann, P. Schweizer, Katus Ha, & Dierk Thomas. (2012). Kardiale Zwei-Porendomänen-Kaliumkanäle (K2P): Physiologie, Pharmakologie und therapeutisches Potenzial. DMW - Deutsche Medizinische Wochenschrift. 137(33). 1654–1658. 8 indexed citations
5.
Jehle, J, Eckhard Ficker, Xiaoping Wan, et al.. (2012). Mechanisms of zolpidem‐induced longQTsyndrome: acute inhibition of recombinanthERG K+channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. British Journal of Pharmacology. 168(5). 1215–1229. 10 indexed citations
6.
Kristen, Arnt V., et al.. (2010). [Return to work after heart transplantation].. PubMed. 62(2). 67–72. 3 indexed citations
7.
Meder, Benjamin, Katus Ha, & Wolfgang Rottbauer. (2009). Genetik der hypertrophischen Kardiomyopathie. Journal für Kardiologie (Krause & Pachernegg GmbH). 16(7). 274–278. 3 indexed citations
8.
Zugck, Christian, Lutz Frankenstein, Manfred Nelles, et al.. (2008). Telemedicine reduces hospitalisation rates in patients with chronic heart failure - results of the randomized HiTel trial. European Journal of Heart Failure Supplements. 7. 9–9. 8 indexed citations
10.
Voelkers, Mirko, et al.. (2006). S100A1 gene transfer in myocardium.. PubMed. 11(10). 418–22. 13 indexed citations
11.
Zehelein, Jörg, Dierk Thomas, Markus Khalil, et al.. (2004). Identification and characterisation of a novel KCNQ1 mutation in a family with Romano–Ward syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1690(3). 185–192. 10 indexed citations
12.
Müller, Oliver J., Marie Lange, H. Lorenzen, et al.. (2003). Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovascular Research. 59(2). 380–389. 78 indexed citations
13.
Müller, Oliver J., Barnabas Gellen, H. Lorenzen, et al.. (2003). 671 Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. European Journal of Heart Failure Supplements. 2(1). 138–138. 3 indexed citations
14.
Jain, Dilip, Claus Bartels, Matthias Bechtel, et al.. (2001). Early Post-Operative Haemodynamic and Neurohumoral Follow-Up After Endoaneurysmorrhaphy. Journal of clinical and basic cardiology. 4(2). 165–167. 1 indexed citations
15.
Jain, Deepak, Frank Hartmann, Katus Ha, & Gert Richardt. (2001). An unusual complication of metallic balloon shaft fracture during coronary angioplasty.. PubMed. 13(4). 314–6. 1 indexed citations
16.
Giannitsis, Evangelos, Katus Ha, Stephanie Lehrke, Gert Richardt, & Uwe Wiegand. (2000). Comparison of direct PCI and front-loaded tissue plasminogen activator for the treatment of patients with right ventricular infarction - a matched-pairs analysis on 174 patients. Journal of clinical and basic cardiology. 3(2). 103–106. 1 indexed citations
17.
Rothmann, Thomas, et al.. (1996). Heart muscle-specific gene expression using replication defective recombinant adenovirus.. PubMed. 3(10). 919–26. 40 indexed citations
18.
Gerhardt, W., Katus Ha, Margit Müller-Bardorff, et al.. (1996). Multicentre evaluation of an immunological rapid test for the detection of troponin T in whole blood samples.. PubMed. 34(7). 591–8. 38 indexed citations
19.
Брем, Г., et al.. (1994). Characterization of a cardiac-selective and developmentally upregulated promoter in transgenic mice.. PubMed. 5(4). 235–43. 9 indexed citations
20.
Ha, Katus, et al.. (1980). Influence of timing of the extrasystolic beat on the extent of postextrasystolic potentiation in the intact human left ventricle. Basic Research in Cardiology. 75(5). 657–667. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026